Show simple item record

dc.contributor.authorSheehan, B
dc.contributor.authorGuo, C
dc.contributor.authorNeeb, A
dc.contributor.authorPaschalis, A
dc.contributor.authorSandhu, S
dc.contributor.authorde Bono, JS
dc.date.accessioned2021-08-12T11:29:37Z
dc.date.available2021-08-12T11:29:37Z
dc.identifier.citationEuropean Urology Focus, 2021
dc.identifier.issn2405-4569
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4755
dc.identifier.doi10.1016/j.euf.2021.06.006
dc.languageeng
dc.language.isoeng
dc.publisherElsevier BV
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleProstate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications
dc.typeJournal Article
dcterms.dateAccepted2021-06-09
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1016/j.euf.2021.06.006
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfEuropean Urology Focus
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group
pubs.publication-statusPublished
pubs.embargo.termsNot known
icr.researchteamProstate Cancer Targeted Therapy Group
icr.researchteamProstate Cancer Targeted Therapy Groupen_US
dc.contributor.icrauthorDe Bono, Johannen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0